BioViva

From WikiMD's Medical Encyclopedia

(Redirected from Liz Parrish)

BioViva is a biotechnology company that focuses on the development of new gene therapies to slow the aging process. The company was founded by Elizabeth Parrish in 2015, who also serves as the CEO. BioViva uses a combination of telomerase gene therapy and myostatin inhibitor to combat aging.

History[edit]

BioViva was founded in 2015 by Elizabeth Parrish, who has a background in advocacy for the use of genetic engineering to combat aging. The company's approach is based on the work of George M. Church, a geneticist at Harvard Medical School.

In 2015, Parrish announced that she had undergone BioViva's experimental therapies to combat aging. This made her the first person to be treated with gene therapy to extend telomere length.

Research and Development[edit]

BioViva's research and development efforts are focused on gene therapies that can slow the aging process. The company's main therapies are based on the activation of the telomerase gene and the inhibition of myostatin.

The telomerase gene therapy is designed to extend the length of telomeres, the protective caps on the ends of chromosomes. Shortening of telomeres is associated with aging and a higher risk of age-related diseases.

The myostatin inhibitor is designed to increase muscle mass and strength, which often decrease with age. Inhibition of myostatin has been shown to increase muscle mass in mice and humans.

Controversies[edit]

BioViva has been the subject of controversy due to its unconventional approach to research and development. The company has been criticized for testing its therapies on its CEO, Elizabeth Parrish, before conducting clinical trials.

See Also[edit]

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
  • BioViva logo
    BioViva logo
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD

WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=BioViva&oldid=6416719"